Wilson Sonsini is synonymous with ushering promising and innovative technology and life sciences companies through their business life cycle. The firm’s experience at the heart of the Silicon Valley ecosystem—working with the top innovators and entrepreneurs, as well as the funding sources that support them—has positioned us to play an active role in the development of the technology and life sciences ecosystems in innovative business centers across the globe. Our attorneys are known for providing practical, actionable, business-minded advice to guide our clients through their strategic transactions, beginning with pre-structuring considerations and continuing throughout the structuring, negotiation, implementation, and completion of a transaction.
Wilson Sonsini has established strong relationships with law firms, investors, and other financial institutions based in Australasia through the course of representing its clients. As a trusted advisor to entrepreneurs, company executives, and board members, we guide Australia and New Zealand-based companies as they launch, scale, raise funding, and “exit” in the U.S. via a U.S. IPO, and thereafter throughout their life cycles as U.S. publicly listed companies, or via a sale transaction involving a U.S. acquiror. In addition, our firm assists U.S.-based clients engaged in acquisitions and commercial transactions in the Australasia region.
Notable capital markets transactions we have handled for our clients include the U.S. IPO of ASX-listed Mesoblast Limited and the $300 million and $700 million convertible note offerings of Xero Limited, a company we’ve advised since 2010. We also advised Westfield Corporation on its spin-off and ASX listing of its U.S.-based OneMarket Limited subsidiary. In addition, our cross-border M&A practice has also been active, teaming with both Australian acquirors, such as MessageMedia Group in its acquisition of U.S.-based SimpleTexting, and Australian sellers, such as Osteon Medical in its sale to U.S.-based Keystone Dental.
Other work on behalf of clients based in Australia and New Zealand—as well as our global clients doing business in Australasia—includes structuring and negotiating collaborations and other strategic agreements, and helping such clients navigate issues involving intellectual property licensing and protection, privacy and data protection, clinical trial arrangements, internal investigations, U.S. Securities and Exchange Commission inquiries and enforcement actions, and other U.S. regulatory and compliance matters.
Contacts:
As a trusted advisor to founders, executives, investors, and board members, we guide companies based in Belgium, the Netherlands, and Luxembourg (Benelux) as they launch, scale, raise funding, and exit in the U.S. via a U.S. IPO, and thereafter throughout their life cycles as U.S. publicly listed companies, or via a sale transaction involving a U.S. acquiror. We similarly counsel Benelux-based investors as they seek to deploy capital in the U.S. and the UK. In addition, in collaboration with our network of law firms and advisors located across Benelux, our attorneys have assisted U.S. clients engaged in corporate and commercial transactions in these countries.
Wilson Sonsini also has one of the largest dedicated data, privacy, and cybersecurity teams in Europe advising on a wide array of data protection issues, including in Benelux. Our services span counseling, transactional privacy, security breaches, and government investigations. In parallel, our European and UK competition team advises on merger control, cartel investigations, abuse of dominance, strategic collaborations, and distribution systems. Our diverse team, licensed across most EU jurisdictions and the UK, is uniquely positioned to address the intricate dynamics between competition law and data protection, in particular the latest EU data-related legislation, such as the Digital Markets Act, Digital Services Act, Data Act, and AI Act.
In addition to the transactional matters mentioned below, Wilson Sonsini’s work on behalf of clients in Benelux—and clients doing business in Benelux—includes structuring and negotiating joint ventures and strategic agreements, and helping clients navigate issues involving intellectual property licensing and protection, privacy and data protection, U.S. Securities and Exchange Commission inquiries and enforcement actions, internal investigations, and other U.S. regulatory and litigation matters.
Netherlands
Wilson Sonsini’s work in the Netherlands derives from building trusted relationships with Dutch clients, teaming with them on their critical transactions. For example, our firm represented Elastic in its U.S. IPO on Nasdaq and thereafter in its life as a U.S.-listed company. Transactions for Elastic included its acquisition of Endgame and its $500 million senior note offering. Wilson Sonsini also advised GeoPhy in its sale to Walker & Dunlop, Wercker in its sale to Oracle, and Grubhub in its $7.8 billion acquisition by Just Eat Takeaway.com.
Further, Wilson Sonsini is involved in organizations and initiatives focused on supporting business relationships between the Netherlands and the U.S. For example, since 2020, Wilson Sonsini has partnered with Holland in the Valley, an ecosystem that empowers Dutch entrepreneurs and talent to innovate and scale in the Bay Area by offering programs, content, and events. The partnership includes mentoring Dutch start-ups and scale-ups on U.S. expansion and fundraising. Wilson Sonsini also provides U.S.-focused support to Dutch start-ups and scale-ups through regular collaboration with ScaleNL and Techleap.
Of note, Wilson Sonsini Senior Of Counsel Tim Broas served as the U.S. Ambassador to the Kingdom of the Netherlands from 2014 to 2016. During that time, he focused on facilitating international business and other diplomatic relationships.
A number of the firm’s attorneys are fluent in Dutch.
Luxembourg
Wilson Sonsini’s work in Luxembourg consists of advising both companies and investors on the full spectrum of legal issues, in particular with regard to venture financing, commercial relationships, and exit events, with a particular focus on cross-border transactions. For example, our firm represented shareholders of LMTS Holding S.C.A (Luxembourg) in their $190 million acquisition by Bird Rides, and Transplant Genomics Inc. in its $71.5 million acquisition by Eurofins Scientific (Luxembourg). The firm has also represented FREYR (Luxembourg) in a number of transactions, including its $704 million de-SPAC with Alussa Energy Acquisition and its definitive license and services agreement to use 24M’s SemiSolid lithium-ion battery platform technology in FREYR’s planned facilities in Mo i Rana, Norway.
Contacts:
Over the last several decades, Wilson Sonsini has formed close, collaborative relationships with Canadian entrepreneurs and companies, as well as law firms, investors, and other financial institutions based in Canada. As a trusted advisor to founders, executives, investors, and board members, we guide Canadian companies as they launch, scale, raise funding, and exit in the U.S. or when negotiating deals with American companies. In addition to supporting Canadian companies with respect to U.S. M&A transactions, we have worked with several Canadian companies on their U.S. IPOs, cross-border listings, and de-SPAC transactions, and continue to support them throughout their life cycles as U.S. publicly listed companies. We similarly counsel Canadian investors as they seek to deploy capital in the U.S. In collaboration with our network of law firms and advisors in Canada, our attorneys have assisted U.S. clients engaged in strategic and commercial transactions across the country.
Wilson Sonsini has established itself as a leading legal advisor on cross-border equity offerings and M&A transactions. For example, Wilson Sonsini advised Vancouver-based Xenon Pharmaceuticals on its U.S. IPO and subsequent follow-on and ATM offerings; Victoria-based Eupraxia on its MJDS filing and Nasdaq listing; and Montréal-founded Sonder in its redomiciliation to the U.S. and subsequent de-SPAC transaction. Our M&A team represented Ottawa-based GaN Systems in its $830 million acquisition by Infineon Technologies and Vancouver-based Absolute Software in its $870 million acquisition by Crosspoint Capital Partners. Of note, Wilson Sonsini was ranked among the top 20 legal advisors, based on the number of Canada announced deals during the year, in Bloomberg’s Global M&A 2023 Legal Rankings.
In addition to capital markets and M&A transactions, our technology transactions group (TTG) helps Canadian companies structure and negotiate joint ventures and other strategic agreements, as well as navigate issues involving intellectual property licensing and protection through strategic commercial transactions. For example, our TTG team represented Toronto-based Ripple Therapeutics Corporation, a clinical-stage, ophthalmology-focused developer of novel therapeutics, in its Series A financing and its exclusive licensing agreement with Théa Open Innovation, a wholly owned subsidiary of leading independent ophthalmology pharmaceutical company Laboratoires Théa, based in France. Wilson Sonsini’s work on behalf of Canadian clients—and clients doing business in Canada—also includes privacy and data protection, U.S. patents and intellectual property strategy, Securities and Exchange Commission inquiries and enforcement actions, internal investigations, investigations conducted by the Federal Trade Commission, and other U.S. regulatory and litigation matters.
Contacts:
Wilson Sonsini has established strong ties to French companies and entrepreneurs through our work on behalf of clients. Additionally, our firm has formed collaborative relationships with French law firms, investors, and other financial institutions. As a trusted advisor to entrepreneurs, executive officers, and board members, we guide French companies as they launch, scale, raise funding, and “exit” in the U.S. via a U.S. IPO, and thereafter throughout their life cycles as U.S. publicly listed companies, or via a sale. We similarly team with French investors as they seek to deploy capital in the U.S. In addition, in conjunction with our network of law firms and advisors across Europe, Wilson Sonsini represents U.S. clients engaged in business and commercial dealings in France and throughout the continent.
Wilson Sonsini can attribute a large degree of its success at building trusted relationships to its work on notable transactions involving French clients. For example, our firm represented Talend S.A. in its U.S. IPO on Nasdaq and thereafter in its life as a U.S. listed company. Transactions we handled for Talend included multiple public offerings through which its pre-IPO investors achieved liquidity, as well as the company’s €150 million convertible note offering. Our representation of Talend culminated in its US$2.4 billion acquisition by Thoma Bravo. Additional French transactions include advising Drivy on its $300 million acquisition by Getaround and representing Rambus in its $85.64 million acquisition of PLDA.
Wilson Sonsini’s work on behalf of French clients—and clients doing business in and around France—includes helping them structure and negotiate joint ventures and strategic agreements and navigate issues involving intellectual property licensing and protection, commercial disputes, U.S. Securities and Exchange Commission inquiries and enforcement actions, internal investigations, and other U.S. regulatory and compliance matters.
Further, we have one of the largest dedicated data, privacy, and cybersecurity teams in Europe advising on a wide array of data protection issues, including in France. Our services span counseling, transactional privacy, security breaches, and government investigations. In parallel, our European and UK competition team advises on merger control, cartel investigations, abuse of dominance, strategic collaborations, and distribution systems. Our diverse team, licensed across most EU jurisdictions and the UK, is uniquely positioned to address the intricate dynamics between competition law and data protection, in particular the latest EU data-related legislation, such as the Digital Markets Act, Digital Services Act, Data Act, and AI Act.
Of note, more than 30 of the firm’s attorneys speak or are fully fluent in French.
Contacts:
As a trusted advisor to founders, executives, investors, and board members, we guide German companies as they launch, scale, raise funding in the U.S. and the UK, exit via a U.S. listing or a sale transaction involving a U.S. or international acquiror, and navigate their life cycles as U.S. publicly listed companies. We similarly counsel German investors as they seek to deploy capital in the U.S. and the UK. In collaboration with our network of German law firms, investors, and advisors, Wilson Sonsini helps our U.S. and international clients structure, negotiate, and complete their strategic business and commercial transactions in Germany, as well as assist them in their dealings with German regulators.
Our corporate work for German clients and clients doing business in Germany includes venture and growth capital financings, equity capital markets, and strategic partnering transactions. For example, Wilson Sonsini represented C4 Therapeutics in its strategic discovery research collaboration agreement with Merck. In addition, we are consistently engaged in cross-border acquisition transactions involving German acquirors and sellers, including representing GaN Systems in its $830 million acquisition by Infineon Technologies and Wallaby Medical in its $500 million acquisition of phenox GmbH. In fact, Wilson Sonsini was ranked among the top 20 legal advisors, based on the number of German announced deals during the year, in Bloomberg’s Global M&A 2023 Legal Rankings.
Wilson Sonsini also has one of the largest dedicated data, privacy, and cybersecurity teams in Europe advising on a wide array of data protection issues, including in Germany. Our services span counseling, transactional privacy, security breaches, and government investigations. In parallel, our European and UK competition team advises on merger control, cartel investigations, abuse of dominance, strategic collaborations, and distribution systems. Our diverse team, licensed across most EU jurisdictions and the UK, is uniquely positioned to address the intricate dynamics between competition law and data protection, in particular the latest EU data-related legislation, such as the Digital Markets Act, Digital Services Act, Data Act, and AI Act.
Wilson Sonsini’s work on behalf of German clients—and clients doing business in Germany—includes helping them structure and negotiate joint ventures and strategic agreements, as well as navigate issues involving intellectual property licensing and protection, U.S. Securities and Exchange Commission inquiries and enforcement actions, internal investigations, and other U.S. regulatory and dispute resolution, privacy and data protection, and regulatory compliance matters.
A number of the firm’s attorneys are fluent in German.
Contacts:
Over the last several decades, Wilson Sonsini has formed close, collaborative relationships with entrepreneurs and companies in Ireland, as well as law firms, investors, and other financial institutions based in the country. As a trusted advisor to founders, executives, investors, and board members, we guide Irish companies as they launch, scale, raise funding, and exit in the U.S. via a U.S. IPO, and thereafter throughout their life cycles as U.S. publicly listed companies, or via a sale transaction involving a U.S. acquiror. We similarly counsel Ireland-based investors as they seek to deploy capital in the U.S. or the UK. In collaboration with our network of Irish law firms and advisors, our attorneys also assist U.S. clients engaged in business affairs throughout Ireland.
In addition to partnering with Irish clients as they raise capital in the U.S. through venture capital financings and U.S. IPOs, Wilson Sonsini has structured and negotiated a substantial number of cross-border Ireland-U.S. transactions. For example, Wilson Sonsini advised Pointy on its sale to Google for $163 million and Decawave on its sale to Qorvo for $400 million. We also represented Zymeworks in its exclusive licensing agreement with Dublin-based Jazz Pharmaceuticals plc and helped Dublin-based Wayflyer raise $76 million in its Series A financing from a global investor base.
Further, we have one of the largest dedicated data, privacy, and cybersecurity teams in Europe advising on a wide array of data protection issues, including in Ireland. Our services span counseling, transactional privacy, security breaches, and government investigations. In parallel, our European and UK competition team advises on merger control, cartel investigations, abuse of dominance, strategic collaborations, and distribution systems. Our diverse team, licensed across most EU jurisdictions and the UK, is uniquely positioned to address the intricate dynamics between competition law and data protection, in particular the latest EU data-related legislation, such as the Digital Markets Act, Digital Services Act, Data Act, and AI Act.
In addition to the transactional and regulatory matters mentioned above, Wilson Sonsini’s work on behalf of Irish clients—and clients doing business in Ireland—includes helping them navigate issues involving intellectual property licensing and protection, U.S. Securities and Exchange Commission inquiries and enforcement actions, internal investigations, and other U.S. regulatory compliance matters.
Contacts:
Wilson Sonsini has strong ties to Israeli companies, entrepreneurs and investors, forged through our decades of work on behalf of clients and our collaborative relationships with Israeli law firms and financial institutions. As a trusted advisor to founders, executives, investors and board members, we represent clients on Israel-related matters through all stages of their life cycle in the U.S., from U.S. launch, expansion and fundraising to U.S. partnerships, M&A events, IPOs and thereafter as U.S. publicly listed companies. We also connect Israel-based companies and investors to our global network of capital providers, corporates and advisors, leveraging our experience in adding value to emerging companies and fostering the growth of technology ecosystems. In addition, Wilson Sonsini represents U.S. investors seeking to deploy capital in Israel.
Our experience and comprehensive range of practices has earned us the opportunity to work with innovators on Israel-related and international matters, including representing Run:AI in its $1 billion acquisition by Nvidia, Silk Security in its $150 million acquisition by Armis, Urgent.ly in its Nasdaq public listing and $282 million acquisition of Otonomo Technologies, Axis Security in its $412 million acquisition by Hewlett Packard, JFrog in its IPO, and the underwriters in WalkMe’s IPO.
Other work on behalf of clients based in Israel—as well as our global clients doing business in Israel—includes structuring and negotiating collaborations and other strategic agreements, and helping such clients navigate issues involving intellectual property licensing and protection, privacy and data protection, clinical trial arrangements, internal investigations, U.S. Securities and Exchange Commission inquiries and enforcement actions, and other U.S. regulatory and compliance matters.
Contacts:
Through our strong ties to law firms, investors, and other entities based in Japan, Wilson Sonsini has assisted clients in their dealings with Japanese companies and financial institutions, among others. As a trusted advisor to founders, executives, investors, and board members, we guide Japanese companies as they launch, scale, raise funding, and exit in the U.S. via a sale transaction involving a U.S. acquiror or an IPO. We similarly counsel Japan-based investors as they seek to deploy capital in the U.S.
Our work for Japanese clients has included representing DeNA in its acquisition of ngmoco, Taiho Pharmaceutical in its $405 million acquisition of Cullinan Pearl, and Shin Nippon Biomedical Laboratories in its acquisition of Satsuma Pharmaceutical. We’ve also advised our U.S. clients on sales to Japanese acquirors, including the sale of Bungie to Sony Interactive Entertainment for $3.6 billion and the sale of the self-driving technology unit of Lyft acquisition to a subsidiary of Toyota for $550 million. In addition, Wilson Sonsini has structured and negotiated joint ventures and strategic agreements involving Japanese clients, such as the strategic collaboration agreements between JIXING and TMS Co.
In addition to the transactional matters mentioned above, Wilson Sonsini’s work on behalf of Japanese clients—and clients doing business in Japan—includes helping clients navigate issues involving intellectual property licensing and protection, U.S. Securities and Exchange Commission inquiries and enforcement actions, internal investigations, CFIUS matters, and other U.S. regulatory and litigation matters.
Of note, Wilson Sonsini has hosted a series of events and meetings focused on Japanese business, technology, and life sciences initiatives. For example, our firm hosted Japan Healthcare Week 2023, a US-Japan Healthcare Connection collaboration, which followed a successful 2022 integrated program between the Japan Society of Northern California and US-Japan Medtech Frontiers, an organization co-founded by Wilson Sonsini.
A number of the firm’s attorneys are fluent in Japanese. Importantly, we are also well versed in business protocol and customs that are inherently important to business dealings and interactions with professionals throughout Japan.
Contacts:
As a trusted advisor to founders, executives, investors, and board members, we guide Korean companies as they launch, scale, raise funding, and exit in the U.S. via a sale transaction involving a U.S. acquiror or a U.S. IPO. In addition, in collaboration with our network of Korean law firms and advisors across Korea, our attorneys have assisted U.S. clients engaged in business affairs in Korea and throughout Asia.
We similarly counsel Korea-based companies and investors as they seek to deploy capital in the U.S. Whether EV batteries, nuclear power, robotics, electronic gaming, AI, biopharmaceuticals, fintech, or any other new technologies and enterprises, we have the expertise to advise Korean companies in the U.S. as part of their global strategy for growth and competitiveness. Consistent with this expertise and our involvement in the U.S. technology ecosystem, we advise multiple businesses within Samsung, LG, Doosan, Hanwha, Celltrion, Naver, and Netmarble. Other transactions we’ve handled include advising CBC Group on its acquisition of a 46.9 percent stake in Hugel for $1.5 billion and representing Elevar Therapeutics in its sale to HLB. In fact, Wilson Sonsini was ranked among the top 20 legal advisors, based on the number of South Korea announced deals during the year, in Bloomberg’s Global M&A 2023 Legal Rankings.
In addition to the transactional matters mentioned above, Wilson Sonsini’s work on behalf of Korean clients—and clients doing business in Korea—includes structuring and negotiating joint ventures and strategic agreements, as well as helping such clients navigate issues involving intellectual property licensing and protection, U.S. Securities and Exchange Commission inquiries and enforcement actions, internal investigations, and other U.S. regulatory and litigation matters, including antitrust and data/privacy counseling.
Of note, several of the firm’s attorneys are fluent in Korean.
Contacts:
Wilson Sonsini brings its unique depth of experience to Latin America, where we represent hundreds of clients—including many anchor unicorns and leading regionally focused investors—in the region’s most dynamic markets, including Brazil, Mexico, Colombia, Argentina, and Chile, among others. Our attorneys have deep knowledge in all the crucial stages of the business life cycle, including experience in company formation, venture financing, expansion, branch operations, joint ventures, spin-offs, capital markets, mergers and acquisitions, antitrust and financial regulation, technology transactions, intellectual property counseling, and more.
Over the last decade, Wilson Sonsini has represented clients in hundreds of deals across Latin America, including some of the region’s most exciting and impactful venture-backed financings and high-profile mergers and acquisitions. Among these are the acquisition of EasyTaxi by Cabify, the merger of Grin and Yellow, the acquisition of Navent by QuintoAndar, the acquisition of Box Delivery by Rappi, the acquisition of OKOL by Habi, and the acquisition of Daitan by Encora.
We have also had the privilege of representing many of the most active and dynamic investors in the Latin American venture finance market, advising key players such as Valor Capital, Kaszek, monashees, and Lightrock, among others.
Wilson Sonsini has pioneered key innovations in the region, including sophisticated venture financing structures, complex corporate reorganizations, and creative solutions to the challenges posed by the region’s unique idiosyncrasies. In addition, our attorneys’ extensive knowledge and experience allow our clients to be exceptionally well positioned to deal with the market’s often challenging characteristics. To learn more, please visit our related Latin America practice page.
Our team consists of several attorneys who are native or fluent in Spanish and Portuguese.
Contact:
Leveraging our established ties in the Nordic countries—Denmark, Finland, Iceland, Norway, and Sweden—Wilson Sonsini has a long track record as a trusted advisor to Nordic-based founders, executives, and board members, guiding them as their companies launch, scale, raise funding, and exit in the U.S. via a U.S. IPO or M&A transaction. We similarly counsel U.S.-based investors on their investments in the Nordics, and Nordic-based investors as they seek to deploy capital in the U.S. and the UK. In addition, in collaboration with our network of law firms and advisors, our attorneys have assisted U.S. clients engaged in transactions throughout the Nordics.
Wilson Sonsini has represented many of the most innovative high-growth enterprises in the Nordics in their transformative transactions and significant legal matters. For example, we represented Kerecis, Iceland’s first “unicorn,” in its $1.3 billion sale to Coloplast. In Denmark, we regularly represent Novo Holdings in a variety of strategic venture financings and IP matters, and represented Aspect Biosystems in its $2.7 billion collaboration with Novo Nordisk. Our work in Finland includes our representation of DoorDash in its $8.1 billion acquisition of Wolt Enterprises and Blackstone in its $566 million investment in Relex. In Sweden, we represented Palette Life Sciences in its $650 million acquisition by Teleflex, Discover Eco in its $110 million acquisition by Cellink, and Message4u in its $1.3 billion acquisition by Sinch AB. In Norway, Wilson Sonsini represented FREYR, a developer of battery cell production capacity, in its U.S. listing via a de-SPAC transaction and its related licensing and services agreement with 24M, and Gelato in its $240 million late-stage financing.
Wilson Sonsini has also helped Nordic clients structure and negotiate joint ventures and strategic agreements, as well as navigate issues involving intellectual property licensing and protection, privacy and data protection, U.S. Securities and Exchange Commission inquiries and enforcement actions, internal investigations, and other U.S. regulatory and litigation matters.
Of note, several of the firm’s attorneys are Nordic natives who are fluent in the local languages.
Contacts:
Wilson Sonsini has established strong relationships in countries and regions in Southeast Asia, particularly in Singapore and Taiwan. As a trusted advisor to founders, executives, investors, and board members, we guide Singaporean, Taiwanese, and other Southeast Asian companies as they launch, scale, raise funding, and exit in the U.S. via a U.S. IPO, and thereafter throughout their life cycles as U.S. publicly listed companies, or via a sale transaction involving a U.S. acquiror. We similarly counsel Singapore- and Taiwan-based investors as they seek to deploy capital in the U.S. or Asia. In the course of representing clients in a wide range of matters, we’ve developed a strong foundation of relationships with local law firms, investors, and other financial institutions based in Singapore and Taiwan. Through this network, our attorneys assist U.S. clients engaged in business affairs across Asia.
In Singapore-based venture and private equity financings, Wilson Sonsini has represented companies such as d-Matrix in its $110 million Series B funding round led by Temasek. We have also represented a variety of Singapore-based investors, including Boyu Capital, HongShan Capital (formerly known as Sequoia China Capital), and Temasek. Recent representations include advising Boyu Capital in connection with the $587 million Series A financing of GDS International, which is headquartered in Singapore and focuses on Southeast Asian data center business; advising Boyu Capital on the acquisition of Quasar Medical, which has assembly facilities in Singapore; advising Temasek on the $400 million Series C financing by UPSIDE Foods; and advising HongShan Capital on the $210 million Series A financing by Envision Digital.
In Taiwan, we took Gogoro public on Nasdaq via a U.S. de-SPAC transaction. We have also advised Taiwan-based clients in contested matters, such as jury trial wins on behalf of Epistar and Cyntec in patent litigation disputes.
As to cross-border M&A transactions, Wilson Sonsini was ranked among the top 20 legal advisors, based on the number and value of Southeast Asia announced deals during the year, in Bloomberg’s Global M&A 2023 Legal Rankings.
In addition to the transactional matters and accolades mentioned above, Wilson Sonsini’s work on behalf of clients based in Singapore, Taiwan, and elsewhere in Southeast Asia—as well as clients doing business in Asia—includes structuring and negotiating joint ventures and strategic agreements, and helping such clients navigate issues involving intellectual property licensing and protection, privacy and data protection, U.S. Securities and Exchange Commission inquiries and enforcement actions, internal investigations, and other U.S. regulatory compliance matters.
Of note, several of the firm’s attorneys are fluent in the primary languages spoken in Singapore and Taiwan.
Contacts:
Please contact Steve Bernard (sbernard@wsgr.com) or your existing contact at our firm for more information about Wilson Sonsini's contacts in global markets around the world.